Table 1.
Primary analysis | Secondary analysis | |
Measure | Estimation (95% CI) | Estimation (95% CI) |
Sensitivity | 61.2% (58.4-64.0) | 54.7% (52.2–57.2) |
Specificity | 88.8% (88.7–88.9) | 88.8% (88.6–88.9) |
Positive-predictive value | 3.2% (3.0–3.4) | 3.7% (3.5–4.0) |
Negative-predictive value | 99.7% (99.7–99.7) | 99.6% (99.6–99.6) |
Positive likelihood ratio | 5.5 (5.2–5.7) | 4.87 (4.65–5.10) |
Negative likelihood ratio | 0.44 (0.41–0.47) | 0.51 (0.48–0.54) |
Primary analysis was performed with exclusion of patients with previously documented TB disease or no documented initiation of antituberculosis therapy within 30 days of TB diagnosis. Secondary analysis was performed with these groups included. CI, confidence interval; TB, tuberculosis.